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The prevalence of hypertension in African Americans (AAs) is among 
the highest in the world, and they are at high risk of developing hyper‐
tension‐related heart, kidney, and brain injury.1,2 The underlying mech‐
anisms of hypertension in AAs is complex, and combination of genetic 
and environmental factors play major role. Salt‐sensitivity, obesity, and 
diabetes in AAs are well‐studied and are directly correlated with hy‐
pertension.3,4 There has been an increasing interest on cardiovascular 
risk factor such as psychological stress in AAs that may contribute to 
increase in blood pressure (BP). AAs experience high socioeconomic 
disparity even today, and they are 20% more likely to report serious 
psychological distress than adult white people.5 Psychological stress 
may increase the susceptibility and severity of hypertension,6 but it 
is not clear whether all psychological stress‐related BP spikes add‐up 
and result in hypertension in the long term? Studies are still underway 
to establish the causality between mental stress and long‐term high 
BP; however, stress is associated with poor diet, smoking, excessive al‐
cohol consumption, anxiety, and depression. There is very little infor‐
mation to date on therapeutic interventions of mental stress‐induced 
increase in BP and future cardiovascular events.
In this issue of Journal of Clinical Hypertension,7 Jeong and col‐
leagues from Augusta University presented their findings on the ben‐
eficial effects of Angiotensin‐II receptor blocker (ARB) irbesartan in 
attenuating the acute mental stress‐induced increase in BP in young 
adult AAs (25 ± 7 years).7 Authors have established the model of 
acute mental‐stressor in AAs and is associated with mild‐increase in 
systolic/diastolic blood pressure (SBP/DBP).8,9 Stressor is a 45‐min‐
ute competitive racing or sports video‐game played against another 
individual for a monetary award, followed by 45 minute of recovery 
period. Precise mechanisms of stress‐induced increase in BP are not 
fully understood, and in this report, authors hypothesized activation 
of renin‐angiotensin system (RAS) and Ang‐II activity as one poten‐
tial mechanism. Exclusion criteria of the study included (a) prescribed 
BP medication, (b) pregnant, (c) food‐allergy, (d) hemoglobin <14 g/
dL, (e) history of angioedema, (f) history of cardiac arrhythmia, (g) 
serum creatinine > 1.6 mg/dL, (h) serum potassium > 5.5 mEq/L, or 
(i) during the menses phase of the menstrual cycle. Screened individ‐
uals were pre‐tested to ensure no adverse effects of ARB. Overall, 
this is a well‐designed study, placebo‐controlled, randomized, dou‐
ble‐blind crossover trial with 132 normotensive healthy young adult 
AAs that were treated either with placebo or ARB (150 mg PO) for 
1 week before subjecting to 45 minute of stress. This was followed 
by two‐week of washout period, and individuals were then subjected 
to a second stressor test. As this is a crossover study, individuals who 
were ARB‐treated in the 1st stressor test received placebo treatment 
in the 2nd stressor test, and vice‐versa for the placebo group of the 
1st stressor test. Hemodynamic parameters during two stress‐test 
(SBP/DBP, heart rate, total peripheral resistance (TPR), stroke vol‐
ume and cardiac output) were recorded and averaged.
As expected, ARB‐treated individuals had lower resting BP (SBP/
DBP) on the experiment day. Stressor led to a significant increase in 
BP in placebo group as early as 15 minutes into the mental stress, 
while this was delayed in the ARB‐treated group to 45 minutes. It 
is important to note that during stress, increase in BP from the rest 
was similar in magnitude in both placebo and ARB treated group, 
the only caveat being, it was delayed in the ARB treated group. It is 
worth mentioning that, impaired post‐stress BP recovery has been 
associated with unfavorable longitudinal BP changes and increased 
risk of cardiovascular outcomes.6 In the recovery period, BP in the 
ARB‐treated group dropped below the resting BP, while in placebo 
group, BP remained elevated and did not return to resting BP even 
at 45 minute of recovery.
Previously, authors showed significant percentage of young AAs 
displayed impaired pressure‐natriuresis in response to stress.9 In 
this study, authors extended their work and demonstrated that ARB 
improved urinary sodium excretion in young AAs during stress and 
this in‐part, may explain the attenuated BP response. Furthermore, 
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vasodilatory effect of irbesartan reduced total peripheral resistance 
in the ARB‐treated group before, during and after stress test, com‐
pared with placebo. Other hemodynamic parameters such as heart 
rate, stoke volume, and cardiac output were not significantly differ‐
ent between ARB and placebo group. The study has several limita‐
tions. The small size of the study population warrants further studies 
in large replication cohorts. Lack of young adult non‐AAs control 
group in this study makes data difficult to interpret in the setting 
of stress‐pressor response. It would be interesting to show the per‐
centage of sodium retainer or excreter in non‐AAs, compared with 
AAs. Although, females were 46% of the study size, it is not clear 
whether authors noticed any sex‐based differences. Additionally, 
the study involves young adult normotensive AAs, and thus, thera‐
peutic efficacy and clinical implication of ARBs in hypertensive AAs 
who experience mental‐stress in everyday life remains unclear.
Major finding of the study is that authors identified the poten‐
tial role of increased Ang‐II and RAS activity in the stress‐induced 
hemodynamic regulation in young adult healthy AAs, and ARB treat‐
ment delayed increase in BP, improved natriuresis, and reduced TPR. 
Authors provided some evidence of blocking Ang‐II activity by irbe‐
sartan in improving hemodynamic response in young AAs. Beneficial 
effects of ARB were associated at least in part, by vasodilation and 
improved urinary sodium excretion.
African Americans are sensitive to stress‐related hemodynamic 
changes. The clinical manifestations may be silent in young age, but 
this should not deter early diagnosis and treatment. Despite prog‐
ress, there is a continuing need for additional study. Future studies 
need to consider investigating some potentially important factors 
such as obesity, insulin resistance, sex, family history of hyperten‐
sion, ongoing background stress, and their interaction with stress‐
induced hypertension. Larger studies with longer tracking trials are 
needed to test whether ARB therapy in young adult AAs at risk of 
stress‐induced hypertension will also attenuate long‐term cardio‐
vascular morbidity and mortality?
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